Rock Creek Group, LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Rock Creek Group, LP

  • $1.05 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$110.08 - $142.92 $757,460 - $983,432
-6,881 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$99.73 - $148.48 $686,242 - $1.02 Million
6,881 New
6,881 $914,000
Q3 2019

Nov 13, 2019
SELL
$37.38 - $49.47 $89,226 - $118,084
-2,387 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$39.79 - $67.01 $94,978 - $159,952
2,387 New
2,387 $105,000

Others Institutions Holding BHVN

# of Institutions
10
Shares Held
565K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.45B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Rock Creek Group, LP Portfolio

Follow Rock Creek Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email